Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Cosmos Health Inc. (COSM) had Revenue of $54.43M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$54.43M
Net Income	$-22.38M
Cost of Goods Sold	$50.12M
Gross Profit	$4.31M
Operating Expenses	$69.97M
Operating Income	$-15.54M
Non-Operating Income/Expense	$-0.64M
Pre-Tax Income	$-16.18M
Normalized Pre-Tax Income	$-16.18M
Income after Taxes	$-16.18M
Income from Continuous Operations	$-16.18M
Consolidated Net Income/Loss	$-16.18M
Normalized Income after Taxes	$-16.18M
EBIT	$-15.54M
EBITDA	$-14.30M
Weighted-Average Shares Outstanding (Basic)	19.15M
Weighted-Average Shares Outstanding (Diluted)	19.15M
Earnings per Share (EPS) (Basic)	$-1.17
Earnings per Share (EPS) (Diluted)	$-1.17
Balance Sheet Financials
Current Assets	$25.46M
Property, Plant, and Equipment	$9.69M
Long-Term Assets	$28.85M
Total Assets	$54.31M
Current Liabilities	$25.76M
Long-Term Debt	$1.56M
Long-Term Liabilities	$4.02M
Total Liabilities	$29.78M
Common Equity	$24.53M
Tangible Shareholders Equity	$16.78M
Shareholders Equity	$24.53M
Common Shares Outstanding	23.60M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.72M
Cash Flow from Investing Activities	$-0.80M
Cash Flow from Financial Activities	$5.05M
Beginning Cash	$3.83M
End Cash	$0.32M
Increase/Decrease in Cash	$-3.52M
Stock-Based Compensation	$1.69M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.99
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.45
Gross Margin	7.92%
Operating Margin	-28.56%
EBIT Margin	-28.56%
EBITDA Margin	-26.27%
Pre-Tax Profit Margin	-29.73%
Profit Margin	-41.12%
Free Cash Flow	$-8.14M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.00
Inventory Turnover	11.51
Receiveable Turnover	3.70
Days Sales in Receivables	98.64
Return on Equity	-65.96%
Return on Tangible Equity	-96.46%
Return on Assets	-29.80%
Return on Investments	-62.01%
Book Value Per Share	$1.04
Free Cash Flow per Share	$-0.42
Operating Cash Flow per Share	$-0.40

Data from Zacks Investment Research, Inc.